Total submissions: 18
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000036713 | SCV000060368 | benign | not specified | 2012-04-03 | criteria provided, single submitter | clinical testing | 2204-7C>G in intron 20 of RYR2: This variant is not expected to have clinical si gnificance because it is not located within the splice consensus sequence and ha s been identified in 1.2% (78/6636) of European American chromosomes and 3/3058 African American chromosomes from a broad, though clinically unspecified populat ion (dbSNP rs147479514, NHLBI Exome Sequencing Project; http://evs.gs.washington .edu/EVS). 2204-7C>G in intron 20 of RYR2 (rs147479514, NHLBI Exome Seq Project ; 1.2%,78/6636) |
Labcorp Genetics |
RCV001093855 | SCV000261985 | benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000265261 | SCV000356241 | likely benign | Arrhythmogenic right ventricular dysplasia 2 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
Illumina Laboratory Services, |
RCV001093855 | SCV000356242 | benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
CHEO Genetics Diagnostic Laboratory, |
RCV000030417 | SCV000901200 | likely benign | Cardiomyopathy | 2017-07-17 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000030417 | SCV000902671 | benign | Cardiomyopathy | 2018-03-09 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001528684 | SCV001159089 | benign | not provided | 2023-11-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001528684 | SCV001844936 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001528684 | SCV002496999 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | RYR2: BP4, BS1, BS2 |
Ambry Genetics | RCV002426527 | SCV002727516 | benign | Cardiovascular phenotype | 2014-12-08 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV003996139 | SCV004822693 | benign | Catecholaminergic polymorphic ventricular tachycardia | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001528684 | SCV005264504 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030417 | SCV000053086 | benign | Cardiomyopathy | 2013-02-15 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV001528684 | SCV001740843 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001528684 | SCV001799581 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000036713 | SCV001921165 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000036713 | SCV001932610 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000036713 | SCV001953916 | benign | not specified | no assertion criteria provided | clinical testing |